1.Investigation on the carriage prevalence of Neisseria meningitidis in healthy population in Jiangsu Province in 2019 and 2020.
Qiang CHEN ; Yan XU ; Xiang SUN ; Yun WU
Chinese Journal of Preventive Medicine 2023;57(2):236-240
In order to investigate carriage status and serum groups distribution of Neisseria meningitidis(Nm) among healthy population in Jiangsu Province, four counties were selected as monitoring sites by random sampling method for cross-sectional study. Throat swab specimens were collected from four monitoring sites in October to November 2019 and November to December 2020 for bacterial culture and Real-time PCR detection. Chi-square test was used to compare the positive rate of Neisseria meningitidis, and multiple logistic regression model was used to analyze the influencing factors of Neisseria meningitidis carrier rate. The results showed that among 1 512 samples, 57 strains of Nm were isolated, and the carrier rate was 3.77%. Serogroup B was the dominant group (36.84%), followed by un-known serogroups (33.33%), serogroup C was the third (17.54%), serogroup W135 and serogroup A were 7.02% and 5.26%, respectively. The carriage rate (8.60%) of 15-20 years old was significantly higher than others (1.77%-3.74%)(Pearson χ2=18.211, P<0.05). Region, age and immunization history were risk factors for Neisseria meningitidis carrier rate. In summary, the Nm carrier rate of healthy population in Jiangsu Province is relatively low, which indicates that the epidemic cases will continue to be sporadic in the future. However, the prevention and control of meningococcal epidemics on campus should be strengthened, and the monitoring of neisseria meningitidis group B should be maintained as it has become the dominant epidemic strain.
Humans
;
Adolescent
;
Young Adult
;
Adult
;
Neisseria meningitidis
;
Meningococcal Infections/prevention & control*
;
Prevalence
;
Cross-Sectional Studies
;
Carrier State/microbiology*
2.Case Report of Acute Peritonitis with Blood Infection of Neisseria meningitidis.
Xian XIA ; Jing LYU ; Xuan CAI ; Yuan Liang HU ; Fei HE ; Guo Ming LI ; Hong Mei YANG
Biomedical and Environmental Sciences 2022;35(2):151-154
Acute Disease
;
Aged
;
Anti-Bacterial Agents/therapeutic use*
;
Bacteremia/microbiology*
;
Female
;
Hepatitis B, Chronic/complications*
;
Hepatitis C, Chronic/complications*
;
Humans
;
Hypersplenism/complications*
;
Liver Cirrhosis/complications*
;
Meningococcal Infections/microbiology*
;
Neisseria meningitidis/isolation & purification*
;
Peritonitis/microbiology*
3.Meningococcal disease and carriage in the Philippines: A review of recent data
Pediatric Infectious Disease Society of the Philippines Journal 2022;23(1):5-9
This article reviews recent data on meningococcal disease and carriage in the Philippines. It aims to provide information on the epidemiology of meningococcal disease, its carriage, data on prevention, and the impact of vaccination on disease and carriage. The World Health Organization considers the Philippines as having low endemicity for meningococcal disease. However, current data underestimates the true burden in the country due to many factors. In recent years, data from the Philippines show a high case-fatality rate since only the septicemic form is being reported. Studies on asymptomatic meningococcal carriage rates are sparse, with one study by Gonzales, et al. investigating the prevalence of meningococcal nasopharyngeal carriage in Filipinos aged 5-24 years old living in an urban setting. The study showed that the overall prevalence of carriage was 3.7% and was highest (9%) among the 10-14 age group. Serogroup B was the most common isolate. Effective meningococcal vaccines are available. Although not included in the National Immunization Program, medical societies recommend giving vaccines to individuals at high risk of infection. Data on local epidemiology accounting for the disease and asymptomatic carriage are important to strengthen future programs on immunization and prevention of meningococcal disease.
Meningococcal Infections
;
Meningococcal Vaccines
4.Progress of serogroup B meningococcal outer membrane vesicle vaccines.
Meng Meng YUE ; Juan XU ; Li XU ; Zhu Jun SHAO
Chinese Journal of Preventive Medicine 2022;56(9):1333-1340
This research and development of MenB meningococcal vaccines includes two technical routes: outer membrane vesicle (OMV) vaccines and recombinant protein vaccines. This article intends to review the development, production and application of MenB meningococcal OMV vaccines in order to provide a reference for the development of MenB meningococcal OMV vaccine in China.
Antigens, Bacterial
;
Humans
;
Meningococcal Infections/prevention & control*
;
Meningococcal Vaccines
;
Neisseria meningitidis, Serogroup B
;
Serogroup
;
Vaccines, Synthetic
5.Experts' consensus on immunization with meningococcal vaccines in China.
Chinese Journal of Epidemiology 2019;40(2):123-128
Meningococcal vaccines in the Chinese market include meningococcal polysaccharide vaccine, meningococcal polysaccharide conjugate vaccine, and a combined vaccine. Meningococcal conjugate vaccines immunization schedules vary by vaccine manufacturer, and often cause confusion in immunization practices. Based on the epidemiological characteristics of meningococcal disease, serogroup distribution of Neisseria meningitidis, and research progress on the immunogenicity and safety of meningococcal vaccines, we developed an experts' consensus on immunization with meningococcal vaccines to provide guidance for immunization providers and for centers for disease control and prevention staff.
China
;
Consensus
;
Humans
;
Immunization
;
Meningococcal Infections/prevention & control*
;
Meningococcal Vaccines/administration & dosage*
;
Vaccines, Conjugate
6.Neonatal Sepsis and Meningitis Caused by Neisseria meningitidis Serogroup B: a Case Report
Yoo Na KIM ; Yong Sung CHOI ; Sung Ho CHA
Pediatric Infection & Vaccine 2018;25(3):165-169
Sepsis and meningitis caused by Neisseria meningitidis are rare in neonates, but neonatal sepsis and meningitis are associated with a high rate of mortality. Meningococcal disease is commonly reported in older children and adolescents and is known to be more prevalent in community settings. In this study, a 16-day-old neonate was diagnosed with serogroup B meningococcal sepsis and meningitis. The baby was treated with antibiotics at the early stages of the infection and was discharged in good condition without any complications. This case report can serve to raise awareness of the incidence and importance of meningococcal infection in neonates, especially serogroup B.
Adolescent
;
Anti-Bacterial Agents
;
Child
;
Humans
;
Incidence
;
Infant, Newborn
;
Meningitis
;
Meningococcal Infections
;
Mortality
;
Neisseria meningitidis
;
Neisseria
;
Sepsis
;
Serogroup
9.Analysis of molecular subtypes and microflora structure of Neisseria meningitidis strains isolated in Jiangxi province.
Meng YANG ; Hai-jian ZHOU ; Hui YUAN ; Chang-hui XIONG ; Xiao-qian XU ; Fu-hui CHEN
Chinese Journal of Preventive Medicine 2013;47(4):342-346
OBJECTIVETo study the molecular subtypes and microflora structure of Neisseria meningitidis (Nm) strains isolated in Jiangxi province.
METHODSA total of 123 Nm strains separately isolated from patients, close contacts and health people in 1976-1987 and 2005-2008 were investigated by multilocus sequence typing (MLST) and PorA subtyping, to test the characteristics of gene Nm and sequence porA. Minimum spanning tree was constructed by using BioNumerics software based on data of MLST; and the microflora structure was then analyzed.
RESULTSThe serogroups of 67 Nm strains isolated in 1976-1987 included group A (43 strains), group B (18 strains), group C (1 strains) and group W135 (5 strains); while the serogroups of 56 Nm strains isolated in 2005-2008 included group A (3 strains), group B (7 strains), group C (45 strains) and 1 ungrouped strain. The total 123 Nm strains could be divided into 40 MLST types; while the 46 strains in group A could be divided into 14 MLST types, 29 out of which belonged to ST-3 type, accounting for 63.0% (29/46) as the dominant type. All of the 29 strains were isolated between 1976 and 1987, while 14 strains were isolated from patients, 9 were from close contacts and 6 were from health people. The 46 strains in group C could be divided into 5 MLST types, 41 out of which belonged to ST-4821 type, accounting for 89.1% (41/46). All of the strains were isolated between 2005 and 2008, 6 strains were isolated from patients, 6 were from close contacts and 29 were from health people. The porA gene of the total 123 Nm strains were classified to 32 different types, including 24 different VR1 types and 22 different VR2 types. The dominant PorA type of the prevalent strain (ST-3 type, group A) between 1976 and 1987 was P1.7-1, 10, accounting for 39.1% (18/46) of the strains in group A; while the 18 strains were isolated from 11 patients, 4 close contacts and 3 health people. The dominant PorA type of the prevalent strain (ST-4821 type, group C) between 2005 and 2008 was P1.20, 9, accounting for 46.3% (19/41) of the ST-4821 strains in group C; while the 19 strains were isolated from 1 close contacts and 18 health people. P1.7-2, 14 dominated since 2006, including 22 strains, accounting for 53.7% (22/41) of the ST-4821 strains in group C, isolated from 6 patients, 5 close contacts and 11 health people. There were no dominant PorA type found in group B and all the 5 strains in group W135 belonged to ST-174 and the PorA type was P1.21, 16, isolating from 3 close contacts and 2 health people between 1979 and 1980.
CONCLUSIONNm isolated in Jiangxi province showed significant gene polymorphism, as well as predominant lineages existing. In different periods, the prevalent lineages varied a lot, as translating from serogroup A: ST-3:P1.7-1, 10 to serogroup C: ST-4821:P1.7-2, 14 nowadays.
Bacterial Typing Techniques ; China ; epidemiology ; Genotype ; Humans ; Meningococcal Infections ; epidemiology ; microbiology ; Neisseria meningitidis ; classification ; genetics ; isolation & purification ; Serotyping
10.Meningococcal Disease and Quadrivalent MenACWY-CRM Vaccine (Menveo(R)).
Korean Journal of Pediatric Infectious Diseases 2012;19(3):89-110
Meningococcal Disease, manifesting as meningitis and septicemia, is a life-threatening bacterial infection that results in significant morbidity and mortality, particularly in childhood. Its epidemic potential and limited opportunities for clinical intervention due to its rapid course present unique public health and clinical challenges. Incidence is highest in infants and young children, with a secondary peak of risk in adolescents. Approximately 10% of cases are fatal and survivors can be left with serious and permanent sequelae including amputations, hearing loss and cognitive impairment. Transmission is only from human-to-human, by infected respiratory tract secretions or saliva and therefore crowding poses a tremendously elevated risk for disease development. Military recruits and university students are at high risk due to the high carriage rate in adolescents, their behavior patterns and close contact. Menveo(R) (Novartis Vaccines and Diagnostics), a novel quadrivalent meningococcal conjugate vaccine directed against meningococcal serogroups A, C, W-135 and Y, has been shown to be immunogenic and well tolerated in all age groups and was recently licensed for use in Korea. Recent cases and deaths among military recruits drew public attention to their elevated risk and the Korean government has recommended vaccination of all new military recruits. Many Korean students seek to attend school, university, or language institutes in countries where routine meningococcal vaccination is required - clinicians should be aware of such requirements to ensure that students are vaccinated prior to arrival in the destination country.
Academies and Institutes
;
Adolescent
;
Amputation
;
Bacterial Infections
;
Child
;
Crowding
;
Dietary Sucrose
;
Hearing Loss
;
Humans
;
Incidence
;
Infant
;
Korea
;
Meningitis
;
Meningococcal Vaccines
;
Military Personnel
;
Neisseria meningitidis
;
Public Health
;
Respiratory System
;
Saliva
;
Sepsis
;
Survivors
;
Vaccination
;
Vaccines


Result Analysis
Print
Save
E-mail